VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding VivoSim Labs, INC. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 51 | 1 | 43 | −7 |
| Shares | 2.29M | 80 | 2.19M | −100.1K (−4.4%) |
| Value | $21.4M | $1.00K | $14.9M | −$6.50M (−30.4%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held VivoSim Labs, INC. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 13,809 | $94.0K | 0.00% |
| Community Bank, N.A. | 5 | $0 | 0.00% |
Sold out (9)
Institutions that held VivoSim Labs, INC. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Credit Suisse AG | 15,607 | $147.0K |
| Dimensional Fund Advisors LP | 12,363 | $116.0K |
| North Star Investment Management Corp. | 750 | $7.00K |
| Eaton Vance Management | 525 | $5.00K |
| The PNC Financial Services Group, Inc. | 330 | $4.00K |
| Citigroup Inc | 370 | $3.00K |
| Banque Cantonale Vaudoise | 360 | $3.00K |
| Advisory Services Network, LLC | 30 | $0 |
| Strategic Blueprint, LLC | 15 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held VivoSim Labs, INC. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 80 | $1.00K |